SDGR:NASDAQSchrodinger, Inc. Analysis
Data as of 2026-09-01 - not real-time
$19.50
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Schrödinger, Inc. is bullish at $19.50, with short-term averages leading the long-term ones. Across the trailing 30 sessions it gained 27.3%. Momentum indicators put RSI at 59.4 (neutral) with MACD reading bullish. Price has been bracketed by support at $14.91 and resistance at $20.48.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 9.9% above the current quote. Revenue is growing at 7.5% on a -21.0% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 58.0%, a beta of 1.63 and a maximum drawdown of 50.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 9.9% above the current quote. Revenue is growing at 7.5% on a -21.0% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 58.0%, a beta of 1.63 and a maximum drawdown of 50.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.
Top Market Events
In the past few days, Schrödinger, Inc. reported second-quarter 2026 results showing revenue of US$58.89 million and a...AI co-scientist Bunsen drives productivity gains amid software model shift.NEW YORK, July 22, 2026--Schrödinger, Inc.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 15.03
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 15.03
- Analyst targets imply +9.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -21.0%
- Analyst targets imply +9.9% versus the current price
- Negative return on equity of -16.2%
Key Metrics & Analysis
Financial Health
Revenue Growth7.50%
Profit Margin-20.98%
P/E Ratio-14.4
ROE-16.17%
ROA-14.44%
Debt/Equity32.83
P/B Ratio4.3
Op. Cash Flow$-126870000
Free Cash Flow$-29163124
Industry P/E30.4
Technical Analysis
TrendBullish
RSI59.4
Support$14.91
Resistance$20.48
MA 20$18.39
MA 50$16.86
MA 200$15.03
MACDBullish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
Target Price$21.43
Upside/Downside9.89%
GradeFair
TypeGrowth
Risk Assessment
Beta1.63
Volatility58.02%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.